Paper Review Records
All Paper Review Records
12 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
LKB1 attenuates the transport activity of GLUT1 by regulating the alternative splicing of PKM1/PKM2 in cervical cancer
Mingzhe Wu; Yaoxing Guo; Jinghua Yang; Enhua Wang; Hong-Tao Xu; Guang-Ping Wu; Huanyu ZhaoShow moreShow less
1. Department of Gynecology, The First Hospital of China Medical University, Shenyang, China.; 2. Department of Pathology, The First Hospital and College of Basic Medical Sciences, China Medical University, Shenyang, China.Show moreShow less
Trastuzumab deruxtecan in HER2-expressing gynecologic cancers from DESTINY-PanTumor02: antitumor activity, safety, and exploratory biomarker analyses
Jung-Yun Lee; Ana Oaknin; Luis Manso; Antonio González-Martín; Iwona Ługowska; Domenica Lorusso; Susana Banerjee; John B. Liao; Chien-Hsing Lu; Naiyarat Prasongsook; Bohuslav Melichar; Chiedozie Anoka; Lindsey Jung; Flavia Michelini; Soham Puvvada; Funda Meric-Bernstam; Vicky MakkerShow moreShow less
1. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.; 2. Medical Oncology Service, Vall d’Hebron Institute of Oncology, Vall d’Hebron Barcelona Hospital Campus, Barcelona, Spain.; 3. Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; 4. Medical Oncology Department and Programme in Solid Tumours CIMA, Cancer Center Clínica Universidad de Navarra, Madrid, Spain.; 5. Center for Excellence in Precision Medicine, Maria Skłodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; 6. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.; 7. Humanitas San Pio X, Milan, Italy.; 8. Gynaecology Unit, The Royal Marsden NHS Foundation Trust, London, UK.; 9. Institute of Cancer Research, London, UK.; 10. Division of Gynecologic Oncology, University of Washington, Seattle, WA, USA.; 11. Department of Obstetrics and Gynecology, Taichung Veterans General Hospital, Taichung, Taiwan.; 12. Division of Medical Oncology, Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand.; 13. Department of Oncology, Palacky University Medical School and University Hospital, Olomouc, Czech Republic.; 14. Global Medicines Development, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.; 15. Oncology Biometrics, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.; 16. Translational Medicine, Oncology R&D, AstraZeneca, Barcelona, Spain.; 17. Clinical Development, Late Oncology, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.; 18. Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; 19. Gynecologic Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; 20. Department of Medicine, Weill Cornell Medical College, New York, NY, USA.Show moreShow less
P16/Ki67 dual staining versus cytology for identifying high-grade cervical intraepithelial neoplasia (CIN2+/CIN3+) in triage management of HR-HPV-positive women: a systematic review and meta-analysis
Hang Zhou; Yu Dai; Hua Zhang; Yuan Yang; Ruoji Pi; Lingling Zhu; Wen ChenShow moreShow less
1. Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.; 2. The State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics, National Institute of Diagnostics and Vaccine Development in Infectious Diseases, School of Public Health, Xiamen University, Xiamen, China.; 3. Mianyang Maternal and Child Health Care Hospital, Mianyang, China.Show moreShow less
Enhanced ovarian cancer diagnosis using deep learning on pelvic ultrasound with integrated clinical data: retrospective multicenter study
Sohyeon Jeong; Hyewon Cho; Jooyeon Kim; Sanghoon Lee; Jae Yun Song; Jin Hwa Hong; Jae Kwan Lee; Seon Kyung Kim; Hyun-Woong ChoShow moreShow less
1. Department of Obstetrics and Gynecology, Korea University Guro Hospital, College of Medicine, Korea University, Seoul, Korea.; 2. Department of Obstetrics and Gynecology, Korea University Anam Hospital, College of Medicine, Korea University, Seoul, Korea.; 3. Department of R&D, Aemasue Corp., Seoul, Korea.; 4. Department of Obstetrics and Gynecology, Asan Medical Center, Seoul, Korea.Show moreShow less
Diagnostic accuracy of the droplet digital PCR POLE mutation test in endometrial cancer: comparison with Sanger sequencing and NGS
Yung-Taek Ouh; Hyun-Woong Cho; Kyung-Jin Min; Jae-Kwan Lee; Yikyeong Chun; Jin Hwa HongShow moreShow less
1. Department of Obstetrics & Gynecology, Korea University Ansan Hospital, Ansan, Korea.; 2. Department of Obstetrics & Gynecology, Korea University Guro Hospital, Seoul, Korea.; 3. Department of Pathology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.Show moreShow less
Clinical practice guideline for high-risk human papillomavirus testing in cervical cancer screening: a consensus statement from the Korean Society of Gynecologic Oncology
Ju-Hyun Kim; Seung-Hyuk Shim; Kyung-Jin Min; Jae-Kwan Lee; Chong Woo Yoo; Min-Jung Kwon; Shin-Wha Lee; Jaeman BaeShow moreShow less
1. Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.; 2. Department of Obstetrics and Gynecology, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Korea.; 3. Department of Obstetrics and Gynecology, Korea University Ansan Hospital, Ansan, Korea.; 4. Department of Obstetrics and Gynecology, Korea University Guro Hospital, Seoul, Korea.; 5. Department of Pathology, National Cancer Center, Goyang, Korea.; 6. Department of Laboratory Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.; 7. Department of Obstetrics and Gynecology, Hanyang University Medical Center, Seoul, Korea.Show moreShow less
FAQ
How long does Journal of Gynecologic Oncology take to review a manuscript?
As of 2026-11-19, CrushSCI has 12 complete review records for Journal of Gynecologic Oncology. The fastest paper went from submission to acceptance in 2 days (Clinical practice guideline for high-risk human papillomavirus testing in cervical cancer screening: a consensus statement from the Korean Society of Gynecologic Oncology, received 2026-01-29, accepted 2026-01-31); the slowest took 452 days. The average is 201.8 days and the median is 207.5 days. The fastest record has an unusually short interval; please check the original source.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
